Company intelligence / Profile preview

Sona Nanotech Inc.

Halifax, Nova Scotia, Canadasonanano.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Sona Nanotech’s Targeted Hyperthermia Therapy has demonstrated strong efficacy in multiple preclinical studies. In models of melanoma and breast cancer as well as immunotherapy-resistant colon cancer ("cold" tumors), the therapy shrank tumors and activated a robust immune response. The company’s gold nanorods are uniquely biocompatible due to their CTAB-free synthesis. First-in-human feasibility studies are being planned.

Therapeutic areas: OncologyNeurologyInfectious Diseases
Modalities: Gold nanorods (GNRs) for photothermal therapy and diagnosticsnanoparticle-based drug delivery
Industry: Biotech

Drug pipeline

1 asset

Targeted Hyperthermia Therapy

Pre-clinical

Indications: Colorectal cancer, Breast cancer, Melanoma

Partnerships

Collaborations with Dalhousie University Medical School for preclinical researchadvisory input from leading U.S. academic medical centers

Beyond the preview

Go deeper on Sona Nanotech Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sona Nanotech Inc..

Explore the full profile